Black Diamond Therapeutics
BDTX
BDTX
50 hedge funds and large institutions have $40.6M invested in Black Diamond Therapeutics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
53% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 17
89% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 9
Holders
50
Holding in Top 10
–
Calls
$45K
Puts
$1K
Top Buyers
| 1 | +$1.72M | |
| 2 | +$651K | |
| 3 | +$476K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$79.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.71K |
Top Sellers
| 1 | -$449K | |
| 2 | -$408K | |
| 3 | -$278K | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$268K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$176K |